SCHEMBL4445095

SCHEMBL4445095

O=C(O)c1cc(Br)cc(CCO)c1O

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.56
AKR1C2 P52895 4/20 0.56
AKR1C1 Q04828 4/20 0.56
AKR1C4 P17516 3/20 0.56
PTPN1 P18031 8/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HMGB1 P09429 3/20 0.41
PTPN2 P17706 4/20 0.40
PTPN6 P29350 4/20 0.40
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
CXCL12 P48061 2/20 0.38
ACMSD Q8TDX5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3490091 0.81 AKR1C3 (0.60) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL19745159 0.78 AKR1C3 (0.78) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL17008903 0.76 KDM4E (0.47) AKR1C3AKR1C2AKR1C1PTPN1KDM4E
SCHEMBL4756950 0.76 ALDH1A1 (0.41) PTPN1HSD17B10ALDH1A1HPGDHMGB1
SCHEMBL4136744 0.75 CYP3A4 (0.54) AKR1C3AKR1C2AKR1C1AKR1C4ALDH1A1
SCHEMBL330545 0.72 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL31068478 0.72 AKR1C3 (0.69) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL8285504 0.72 AKR1C3 (0.69) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL29387062 0.72 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL23043923 0.72 PTPN1 (0.42) PTPN1HSD17B10ALDH1A1HPGDHMGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134343-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2009-12-23 EP disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 WO disclosed